Search filters

List of works by Sara A Hurvitz

Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients

scientific article published on 13 April 2012

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer

scientific article published on February 2017

Clinical features of pseudocirrhosis in metastatic breast cancer

scientific article published on 07 June 2019

Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study

scientific article

Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy

scientific article published on 21 October 2019

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

scientific article published on 17 November 2020

Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial

scientific article published on 01 September 2018

Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response

scientific article published on 08 April 2021

Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

scientific article published on 25 November 2019

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial

scientific article published on 20 August 2020

Paulina is supported by:

About Paulina

Help